Equity (Tables)

9 Months Ended

Sep. 26, 2025

Equity [Abstract]

Schedule of Loss per Share

The weighted-average number of shares outstanding used in the computations of basic and diluted loss per share were as follows (in millions of shares):

	Three Months Ended		Nine Months Ended
	September 26, 2025	September 27, 2024	September 26, 2025	September 27, 2024
Basic	32.3	19.7	23.9	19.7
Dilutive impact of restricted share units	—	—	—	—
Diluted	32.3	19.7	23.9	19.7

Schedule of Antidilutive Securities Excluded from Computation of Loss Per Share

Contingent value rights held by the Opioid Master Disbursement Trust II and outstanding equity awards that could potentially dilute per share amounts in the future were as follows (in millions of shares):

	Three Months Ended		Nine Months Ended
	September 26, 2025	September 27, 2024	September 26, 2025	September 27, 2024
Potentially dilutive share amounts	2.1	1.8	2.1	1.7